Dr G R Reyes joins Ben­itec as Se­nior Sci­en­tific Ad­vi­sor

BioSpectrum (Asia) - - People News -

Ben­itec Bio­pharma Lim­ited, a Sydney based clin­i­cal­stage biotech­nol­ogy com­pany de­vel­op­ing novel ge­netic medicines via the pro­pri­etary DNA-di­rected RNA in­ter­fer­ence (ddRNAi) plat­form com­bin­ing RNA in­ter­fer­ence with gene ther­apy, re­cently an­nounced that Gre­gory R. Reyes, M.D., Ph.D., has joined the com­pany as Se­nior Sci­en­tific Ad­vi­sor. As the Se­nior Sci­en­tific Ad­vi­sor, Dr Reyes will lead the com­pany’s ef­forts to ad­vance and ex­pand its port­fo­lio of gene ther­apy prod­ucts. His lead­er­ship and vi­sion will be in­te­gral to the achieve­ment of the op­er­a­tional and strate­gic goals re­gard­ing the Com­pany’s key in­di­ca­tions and re­search pro­grammes. Dr Reyes will also over­see the ex­pan­sion of the com­pany’s sci­en­tific op­er­a­tions to fa­cil­i­tate the suc­cess­ful ex­e­cu­tion of the Com­pany’s broad based re­search col­lab­o­ra­tion with Ax­o­vant, com­pris­ing five ad­di­tional, fully funded re­search pro­grammes tar­get­ing neu­ro­log­i­cal dis­or­ders. Dr Reyes brings over 30 years of suc­cess­ful R&D lead­er­ship ex­pe­ri­ence in ma­jor biotech­nol­ogy and phar­ma­ceu­ti­cal com­pa­nies.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.